Chemours
421 hedge funds and large institutions have $2.48B invested in Chemours in 2024 Q3 according to their latest regulatory filings, with 63 funds opening new positions, 126 increasing their positions, 115 reducing their positions, and 75 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 3 → 6 (+3)
37% more call options, than puts
Call options by funds: $38M | Put options by funds: $27.8M
3.23% more ownership
Funds ownership: 78.51% → 81.73% (+3.2%)
10% more repeat investments, than reductions
Existing positions increased: 126 | Existing positions reduced: 115
3% less funds holding
Funds holding: 435 → 421 (-14)
6% less capital invested
Capital invested by funds: $2.64B → $2.48B (-$159M)
16% less first-time investments, than exits
New positions opened: 63 | Existing positions closed: 75
Top Buyers
| 1 |
AWAM
Appian Way Asset Management
New York
|
+$34.4M |
| 2 |
VOMP
Vision One Management Partners
Miami,
Florida
|
+$28.4M |
| 3 |
Millennium Management
New York
|
+$24.3M |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
+$13.8M |
| 5 |
SCM
Scopia Capital Management
New York
|
+$13.7M |
Top Sellers
| 1 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$19.8M |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
-$18.1M |
| 3 |
JP Morgan Chase
New York
|
-$13.5M |
| 4 |
VNIM
Vaughan Nelson Investment Management
Houston,
Texas
|
-$13.4M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$7.08M |
CC Hedge Fund Activity: Q3 2024 in Review
421 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Chemours (CC) for Q3 2024, worth a combined $2.48B — down 6% from $2.64B a quarter earlier.
Sellers outnumbered buyers: 75 funds closed out of CC and 63 opened new positions — a net loss of 12 holders — while 115 trimmed existing stakes and 126 added.
The largest buyer was Appian Way Asset Management, opening a new position worth an estimated $34.4M. The largest seller was Massachusetts Financial Services, cutting an estimated $19.8M.
- 421 institutional investors held Chemours (CC) as of Q3 2024, down from 435 in Q2 2024.
- Funds reported $2.48B of Chemours stock for Q3 2024, down 6% quarter-over-quarter.
- 63 funds opened new Chemours positions in Q3 2024 and 75 closed out, a net change of -12 holders.
- The largest Chemours buyer in Q3 2024 was Appian Way Asset Management, an estimated $34.4M added.
- The largest Chemours seller in Q3 2024 was Massachusetts Financial Services, an estimated $19.8M sold.
Based on aggregated 13F filings for Q3 2024.